Internal Medicine · Sylacauga, AL
NPI
1073527826
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
209 W Spring St, Suite 200
Sylacauga, AL, 35150
Phone (256) 245-5241
Groups this clinician bills Medicare through
Medicare paid, 2024
$207K
6,054 services
Medicare patients, 2024
592
Average age 74
Drug cost, 2024
$4.3M
84,736 prescriptions
Company payments, 2025
$307
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohamed A Aldaher was code 99308 (snf e&m), 1,932 times for 244 patients. In total Mohamed A Aldaher billed 6,054 services in 49 codes, and Medicare paid $207K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Facility | 1,932 | 244 | $49.28 | $95K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,920 | 21 | $0.09 | $166 |
| 99213 Office E&M - Established | Office | 459 | 201 | $51.47 | $24K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 431 | 182 | $10.76 | $4,636 |
| 99232 Hospital E&M - Subsequent | Facility | 424 | 118 | $57.24 | $24K |
| 99238 Hospital Discharge Management | Facility | 149 | 114 | $58.12 | $8,660 |
| 99223 Hospital E&M - Initial | Facility | 119 | 95 | $120.35 | $14K |
| 99214 Office E&M - Established | Office | 117 | 55 | $65.57 | $7,672 |
| 99304 SNF E&M | Facility | 62 | 61 | $56.55 | $3,506 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 46 | 19 | $0.33 | $15.16 |
| G0008 Administration of influenza virus vaccine | Office | 34 | 34 | $28.59 | $972 |
| 90662 Vaccine Product | Office | 31 | 31 | $81.50 | $2,527 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 29 | 12 | $0.69 | $20.11 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 29 | 29 | $119.54 | $3,467 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 28 | 28 | $23.52 | $658 |
By year: 2022 $182K for 3,369 services; 2023 $208K for 3,822 services; 2024 $207K for 6,054 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87428 Infectious Agent Detection by DNA/RNA | 18 | 17 | $68.88 | $1,240 |
| 0241U Infectious Agent Detection by DNA/RNA | 13 | 12 | $118.28 | $1,538 |
Medicare prescription drug claims, 2024
In 2024, the drug Mohamed A Aldaher prescribed most often to Medicare patients was Amlodipine Besylate, with 3,711 prescriptions and refills. In total Mohamed A Aldaher wrote 84,736 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 3,711 | 5,337 | 439 | $22K |
| Atorvastatin Calcium Generic | 3,310 | 4,344 | 313 | $26K |
| Pantoprazole Sodium Generic | 2,405 | 3,139 | 239 | $30K |
| Levothyroxine Sodium Generic | 2,301 | 2,832 | 167 | $15K |
| Furosemide Generic | 2,142 | 2,461 | 199 | $9,696 |
| Trazodone Hcl Generic | 2,053 | 2,197 | 146 | $11K |
| Eliquis Apixaban | 2,047 | 2,120 | 119 | $501K |
| Omeprazole Generic | 1,958 | 2,878 | 343 | $21K |
| Carvedilol Generic | 1,913 | 2,438 | 184 | $13K |
| Potassium Chloride Generic | 1,806 | 2,060 | 155 | $18K |
| Losartan Potassium Generic | 1,786 | 2,545 | 212 | $15K |
| Lisinopril Generic | 1,485 | 2,416 | 188 | $8,807 |
| Sertraline Hcl Generic | 1,474 | 1,632 | 103 | $9,422 |
| Alprazolam Generic | 1,454 | 1,462 | 175 | $6,220 |
| Donepezil Hcl Generic | 1,429 | 1,483 | 63 | $12K |
Brand drugs: 8,078 claims; generic drugs: 76,395 claims; opioid claims: 2,258.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohamed A Aldaher $307 ($307 in general payments such as food, travel and fees) from 8 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $77.08.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $77.08 |
| Corcept Therapeutics CORT | 3 | $70.91 |
| Ardelyx, Inc. ARDX | 2 | $45.93 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $39.51 |
| Dexcom, Inc. DXCM | 1 | $22.35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $19.11 |
| Novo Nordisk Inc NVO | 1 | $17.74 |
| Pfizer Inc. PFE | 1 | $14.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.